Half Year Macro & Equity Market Report 2025 – Searching for the 4th “C” – In the Foothills of the UK Market Recovery
Jamie Constable, Markets Strategist at Singer Capital Markets, reviews H1 of 2025 and looks at how it has turned out as compared to our previous 2025 Outlook Report We thought Trump 2.0 could bring increased volatility in financial markets and we haven’t been disappointed so far in 2025! From tariffs to Liberation Day and “bombs as the new diplomacy” financial markets have had a lot to deal with. UK equity markets have developed good positive momentum from Liberation Day lows. We search for the “4th C,” Confidence and see UK markets as in the foothills of their recovery.
Reports
Proudly Supporting The Sunday Times Hundred 2025
Singer Capital Markets is proud to support The Sunday Times Hundred, the annual ranking that celebrates Britain’s fastest-growing private companies. The Sunday Times Hundred shines a spotlight on the country’s most dynamic and ambitious private companies. These businesses are driving innovation, creating transformative solutions, and fuelling economic growth across the UK.
Singer Capital Markets News
Appointment as Nominated Advisor and Broker to TheraCryf plc
Singer Capital Markets is delighted to have been appointed as Nominated Advisor and Sole Broker to SkinBioTherapeutics plc with immediate effect.
Deal Announcements
Appointment as Corporate Broker of HSS Hire Group plc
Singer Capital Markets is delighted to have been appointed as Corporate Broker to HSS Hire Group plc with immediate effect.
Deal Announcements
Appointment as Corporate Broker of Solvonis Therapeutics plc
Singer Capital Markets is delighted to have been appointed as Corporate Broker to Solvonis Therapeutics plc with immediate effect.
Deal Announcements
Appointment as Corporate Broker of Stelrad Group plc
Singer Capital Markets is delighted to have been appointed as Corporate Broker to Stelrad Group plc with immediate effect.
Deal Announcements
Appointment as Nominated Advisor and Sole Broker to SkinBioTherapeutics plc
Singer Capital Markets is delighted to have been appointed as Nominated Advisor and Sole Broker to SkinBioTherapeutics plc with immediate effect.
Deal Announcements
Appointment as Corporate Broker of Big Technologies plc
Singer Capital Markets is delighted to have been appointed as Corporate Broker to Big Technologies plc with immediate effect.
Deal Announcements
Singer Capital Markets makes strategic hires to strengthen its Investment Banking division
Sara Hale and Graham Hertrich have joined as Head of Investment Banking and Deputy Head of Investment Banking, respectively. Both Sara and Graham bring exceptional talent and experience that will help drive Singer’s strategic objectives of becoming the pre-eminent investment bank in the small and mid-cap market.
Singer Capital Markets News
Can we turn AIM into the next Nasdaq? Tim Cockroft discusses AIM for The Sunday Times
Singer Capital Markets’ Founder, Tim Cockroft discussed in The Sunday Times the future of AIM and how we should leverage its 25-year legacy – strengthening it and turning it into the Nasdaq of London.
Singer Capital Markets News